Individuals with intellectual disability, as with all people, may experience mental health and behavioral problems which require treatment.  In order to assure that psychiatric and behavioral treatments are used in accordance with current standards of medical practice, the Department of Developmental Services (DDS) requires that all use of behavior modifying medications and behavioral support plans that include the use of aversive procedures be reviewed and approved.  The PRC reviews the use of behavior modifying medications and behavioral support plans for individuals placed or treated under the direction of the Commissioner in DDS operated, funded, and/or licensed facilities or programs, supports and services.  A group of professionals, including a psychiatrist, review individual behavior treatment plans and behavior modifying medications to ensure that they are clinically sound, supported by proper documentation and rationale, and are being proposed for use in conformance with department policies.  Following a review of the PRC recommendations, the director grants or denies approval of the treatment.